Skip to main content
. 2020 Feb 26;7(3):ofaa065. doi: 10.1093/ofid/ofaa065

Table 1.

Reasons for Attrition of Cases

Target Population No. %
Patients with ICD9-diagnosis of CAP during the enrollment window (June 30, 2011–May 30, 2015)
Patients with ≥1 prescription fill for any of the 9 antibiotics of interest (amoxicillin, amoxicillin-clavulanate, ceftriaxone, azithromycin, clarithromycin, levofloxacin, moxifloxacin, ciprofloxacin, doxycycline) during the enrollment window within 3 days of CAP claim 890 784 100.0
Exclusion Criteria No. %
Patients without continuous enrollment in medical and pharmacy benefits for at least 12 months before the index date 676 642 76.0
Patients without continuous enrollment in medical and pharmacy benefits for a minimum of 30 days after the index date 654 105 73.4
Hospitalization for any reason within 2 days of index prescription claim 618 326 69.4
Patients with prescription fills for any antibiotic in the 30 days before diagnosis of CAP 508 384 57.1
Patients with medical claim containing a primary diagnosis of CAP in the 30 days before the first outpatient medical claim in the enrollment window 498 408 56.0
Patients with HMO enrollment 424 577 47.7
Patients on combination antibiotics 413 801 46.5
Sample size after applying all pre- and postindex eligibility requirements 413 801 46.5
Patients aged ≥18 years (final sample size) 257 165

Of this population, 257 165 were aged ≥18 years and served as the primary focus of subsequent analysis.

Abbreviations: CAP, community-acquired pneumonia; HMO, Healthcare Maintenance Organization.

aSample size = 413 801 after all inclusion/exclusion criteria were met.